Targeting a specific protein pathway to improve melanoma treatment
Targeting the SKP2 Axis for Anti-melanoma Therapy
This study is looking at a protein called SKP2 to see how it affects melanoma, a serious type of skin cancer, with the goal of finding better treatment options that are more suited to individual patients.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Beth Israel Deaconess Medical Center NIH-funded |
| Lab location | 1 site (Boston, United States) |
| Project ID | NIH-11123811 on NIH RePORTER |
What this research studies
This research investigates the role of the SKP2 protein in melanoma, a highly aggressive form of skin cancer. By analyzing how SKP2 and other related proteins contribute to the development and progression of melanoma, the research aims to identify new therapeutic targets. The approach includes studying the molecular mechanisms involved in melanoma and exploring how targeting these pathways can enhance treatment effectiveness. Patients may benefit from improved treatment options that are tailored to their specific tumor characteristics.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with melanoma, particularly those with specific genetic alterations in their tumors.
Not a fit: Patients with non-melanoma skin cancers or those whose melanoma has already progressed beyond treatment options may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective therapies for melanoma, potentially improving survival rates and quality of life for patients.
How similar studies have performed: Other research has shown promising results in targeting similar protein pathways in cancer treatment, indicating that this approach may be effective.
Where this research is happening
Boston, United States
- Beth Israel Deaconess Medical Center — Boston, United States (Active)
Researchers
- Principal investigator: Inuzuka, Hiroyuki — Beth Israel Deaconess Medical Center
- Study coordinator: Inuzuka, Hiroyuki
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.